← Leaderboards
Shuren Zhu
Radix Pharmaceuticals, Inc.
$5,140,325
Attributed
$5,140,325
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $941.2K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,140,325 · 10
By mechanism
R44$2,843,317 · 3
R43$2,297,008 · 7
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsGrowthEvaluationBiological AvailabilityTherapeutic IndexPre-ClinicalPharmaceutical PreparationsDoseToxic EffectInvestigational New Drug ApplicationRodent ModelResistanceMalariaScale UpAntimalarialsParasitesGenerationsPlasmodium FalciparumCommunicable DiseasesPreclinical StudyKillingsCessation Of LifeBiological FactorsPharmacologic Substance
Grant awards (15)
Discovery of Small Molecules as Antimalarial Agents$256,500
R43 · FY2021 · AI · contact PI
Development of Natural Product Derivatives as Antiprotozoal Agents$225,000
R43 · FY2018 · AI · contact PI
Evaluation of Natural Products and Derivatives as Antimalarial Agents$225,000
R43 · FY2017 · AI · contact PI
Development of Small Molecules as Antiprotozoal Agents$749,856
R44 · FY2013 · AI · contact PI
Development of Small Molecules as Antiprotozoal Agents$490,480
R44 · FY2012 · AI · contact PI
Preclinical Studies of Natural Product Derivatives as Antimalarial Agents$450,748
R44 · FY2012 · AI · contact PI
Preclinical Studies of Natural Product Derivatives as Antimalarial Agents$547,433
R44 · FY2011 · AI · contact PI
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum$300,000
R43 · FY2009 · AI · contact PI
Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.$290,628
R43 · FY2009 · AI · contact PI
Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.$300,000
R43 · FY2008 · AI · contact PI
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum$300,000
R43 · FY2008 · AI · contact PI
Pre-Clinical Development of Natural Product Analogues as Antimalarial Agents$304,920
R44 · FY2007 · AI · contact PI
Development of Natural Product as Antimalarial Agent$299,880
R43 · FY2007 · AI · contact PI
Pre-Clinical Development of Natural Product Analogues as Antimalarial Agents$299,880
R44 · FY2006 · AI · contact PI
Synthesis and Evaluation of Novel Antimalarial Agents$100,000
R43 · FY2005 · AI